Page last updated: 2024-10-23

bupivacaine and Amyotrophic Lateral Sclerosis

bupivacaine has been researched along with Amyotrophic Lateral Sclerosis in 1 studies

Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mishra, P1
Govil, N1
Parameswaran, P1
Gupta, B1

Other Studies

1 other study available for bupivacaine and Amyotrophic Lateral Sclerosis

ArticleYear
Transverse abdominis plane block for surgical anesthesia in a patient with flail arm syndrome.
    Korean journal of anesthesiology, 2020, Volume: 73, Issue:3

    Topics: Abdominal Muscles; Amyotrophic Lateral Sclerosis; Anesthesia; Arm; Bupivacaine; Humans; Male; Middle

2020